Markus D. Sachs

771 total citations
15 papers, 616 citations indexed

About

Markus D. Sachs is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Markus D. Sachs has authored 15 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Markus D. Sachs's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Virus-based gene therapy research (3 papers). Markus D. Sachs is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (6 papers) and Virus-based gene therapy research (3 papers). Markus D. Sachs collaborates with scholars based in Germany, United States and Netherlands. Markus D. Sachs's co-authors include Stefan A. Loening, Ronald Rodríguez, Dietmar Schnorr, Frank Koenig, H Pflueger, Claus Riedl, Kurosch Daha, Horst Schlechte, Klaus Jung and Monika Jung and has published in prestigious journals such as The Journal of Urology, Journal of Pharmacology and Experimental Therapeutics and European Urology.

In The Last Decade

Markus D. Sachs

15 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus D. Sachs Germany 10 318 232 170 157 119 15 616
Jain-Hua Zhou United States 9 201 0.6× 393 1.7× 164 1.0× 81 0.5× 101 0.8× 9 580
Joseph V. Briggman United States 12 405 1.3× 533 2.3× 132 0.8× 21 0.1× 97 0.8× 19 903
Olivia Alder United Kingdom 12 475 1.5× 266 1.1× 84 0.5× 63 0.4× 78 0.7× 16 694
Michela Tebaldi Italy 11 184 0.6× 60 0.3× 152 0.9× 73 0.5× 138 1.2× 23 442
Tomoyo Takeuchi Japan 13 221 0.7× 62 0.3× 100 0.6× 64 0.4× 73 0.6× 18 442
N Satake Japan 9 192 0.6× 56 0.2× 82 0.5× 136 0.9× 133 1.1× 18 485
Ryan Ybarra United States 3 222 0.7× 52 0.2× 389 2.3× 112 0.7× 61 0.5× 3 589
Pawadee Lohavanichbutr United States 14 555 1.7× 123 0.5× 202 1.2× 56 0.4× 146 1.2× 15 925
Raymond Washington United States 8 219 0.7× 109 0.5× 98 0.6× 13 0.1× 32 0.3× 9 424
Johanna M.M. van Oers Netherlands 14 446 1.4× 521 2.2× 122 0.7× 81 0.5× 96 0.8× 16 857

Countries citing papers authored by Markus D. Sachs

Since Specialization
Citations

This map shows the geographic impact of Markus D. Sachs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus D. Sachs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus D. Sachs more than expected).

Fields of papers citing papers by Markus D. Sachs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus D. Sachs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus D. Sachs. The network helps show where Markus D. Sachs may publish in the future.

Co-authorship network of co-authors of Markus D. Sachs

This figure shows the co-authorship network connecting the top 25 collaborators of Markus D. Sachs. A scholar is included among the top collaborators of Markus D. Sachs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus D. Sachs. Markus D. Sachs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Christoph, Frank, Markus D. Sachs, Joerg Schroeder, et al.. (2020). Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies. Urologia Internationalis. 104(3-4). 181–186. 13 indexed citations
2.
Ecke, Thorsten, Horst Schlechte, Markus D. Sachs, et al.. (2010). TP53 gene mutations in prostate cancer progression.. PubMed. 30(5). 1579–86. 71 indexed citations
3.
Sachs, Markus D., et al.. (2008). OPTICAL COHERENCE TOMOGRAPHY (OCT) FOR THE DIAGNOSIS OF UROTHELIAL BLADDER CANCER: SENSITIVITY AND SPECIFICITY COMPARED TO WHITE LIGHT CYSTOSCOPY. The Journal of Urology. 179(4S). 581–581. 1 indexed citations
4.
Ecke, Thorsten, Markus D. Sachs, S Lenk, Stefan A. Loening, & Horst Schlechte. (2008). TP53 gene mutations as an independent marker for urinary bladder cancer progression. International Journal of Molecular Medicine. 21(5). 655–61. 23 indexed citations
5.
Höti, Naseruddin, Wasim H. Chowdhury, Jer‐Tsong Hsieh, et al.. (2006). Valproic Acid, a Histone Deacetylase Inhibitor, Is an Antagonist for Oncolytic Adenoviral Gene Therapy. Molecular Therapy. 14(6). 768–778. 46 indexed citations
6.
Sung, Jennifer, Michael R. Cohen, Wasim H. Chowdhury, et al.. (2006). Valproic Acid Inhibits Invasiveness in Bladder Cancer but Not in Prostate Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 319(2). 533–542. 33 indexed citations
7.
Jung, Monika, et al.. (2006). Identification and Validation of Suitable Endogenous Reference Genes for Gene Expression Studies of Human Bladder Cancer. The Journal of Urology. 175(5). 1915–1920. 103 indexed citations
8.
Staack, Andrea, Horst Schlechte, Markus D. Sachs, et al.. (2006). Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53. International Journal of Urology. 13(8). 1092–1097. 9 indexed citations
9.
Johannsen, Manfred, Markus D. Sachs, Jan Roigas, et al.. (2005). Phase II Trial of Weekly Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Transitional Cell Cancer. European Urology. 48(2). 246–251. 5 indexed citations
10.
Riedl, Claus, Markus D. Sachs, Frank Koenig, et al.. (2005). LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDY. The Journal of Urology. 174(6). 2129–2133. 149 indexed citations
12.
Sachs, Markus D., Henk G. van der Poel, Thomas J. Wickham, et al.. (2004). Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells. Cancer Gene Therapy. 11(7). 477–486. 54 indexed citations
13.
Sachs, Markus D., Katherine A. Rauen, Jennifer L. Dodson, et al.. (2002). Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology. 60(3). 531–536. 93 indexed citations
14.
Sachs, Markus D., Horst Schlechte, Sebastian Brenner, et al.. (2000). Genetic Analysis of Tp53 from Urine Sediment as a Tool for Diagnosing Recurrence and Residual of Bladder Carcinoma. European Urology. 38(4). 426–433. 8 indexed citations
15.
Schlechte, Horst, Markus D. Sachs, S Lenk, et al.. (2000). Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.. PubMed. 24(1). 24–32. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026